IPOs and Catalysts/Events, Global Equity Research Ltd

Arun George

IPOs and Catalysts/Events

Uncompromised, Independent, Conflict-Free Research

Global Equity Research Ltd

Global Equity Research was started in 2017 by a group of experienced research professionals. It was founded on a passionate belief in the importance and the need for uncompromised, independent, conflict-free research. We aim to provide differentiated and actionable primary and bottom up fundamental research.

Equity Capital Markets

Qingdao Ainnovation Technology Group / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/ainnovation-technology" target="_blank" data-smartkarma-citation="entities:35386:1" rel="noopener">AInnovation Technology (AIT HK)</a> is a fast-growing enterprise AI solutions provider in China. It is set to launch an HKEx IPO to raise up to US$157 million.  </li>
<li>The fundamentals are mixed as diverging growth profiles of key segments, low market share and cash burn are accompanied by a narrowing loss margin. </li>
<li>Overall, we believe the negatives outweigh the positives and we would give the IPO a pass. </li>
</ul>



AInnovation Technology (AIT HK) is a fast-growing enterprise AI solutions provider in China. It is set to launch an HKEx IPO to raise up to US$157 million.  
The fundamentals are mixed as diverging growth profiles of key segments, low market share and cash burn are accompanied by a narrowing loss margin. 
Overall, we believe the negatives outweigh the positives and we would give the IPO a pass. 


AInnovation Technology IPO Initiation: Code Amber

SenseTime Group  / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/sensetime-group" target="_blank" data-smartkarma-citation="entities:34319:1" rel="noopener">SenseTime Group (1475539D HK)</a> has relaunched its HKEx IPO with an unchanged IPO price range and target raise of up to US$768 million. Pricing is set for 23 December.</li>
<li>In <a href="https://www.smartkarma.com/insights/sensetime-ipo-initiation-big-brother" target="_blank" data-smartkarma-citation="insights:62104" rel="noopener">SenseTime IPO Initiation: Big Brother</a>, we stated that the negatives outweigh the positives and we would give the IPO a pass.</li>
<li>Our base-case DCF value is HK$3.48 per share, -11% below the mid-point of the IPO price range. Our DCF sensitivity analysis shows that the IPO price remains unattractive.   </li>
</ul>



SenseTime Group (1475539D HK) has relaunched its HKEx IPO with an unchanged IPO price range and target raise of up to US$768 million. Pricing is set for 23 December.
In SenseTime IPO Initiation: Big Brother, we stated that the negatives outweigh the positives and we would give the IPO a pass.
Our base-case DCF value is HK$3.48 per share, -11% below the mid-point of the IPO price range. Our DCF sensitivity analysis shows that the IPO price remains unattractive.   


SenseTime IPO: Relaunched but Remains a Pass

Pan-Asia Index Rebalances/ Events/ Delta One, Periscope Analytics

Brian Freitas

Pan-Asia Index Rebalances/ Events/ Delta One

Event-Driven

<ul>
<li>Yesterday, the Financial Times reported that the Biden Administration would add two dozen Chinese companies to the entity list while there could be additions to the investment blacklist too.</li>
<li>There was a big drop in biotech stocks in Hong Kong on the news with the Hang Seng Hong Kong listed Biotech Index dropping over 7%.</li>
<li>Ahead of the publication of the lists on Thursday, we look at the potential impact on the stocks that could be added to either/both the lists.</li>
</ul>


Yesterday, the Financial Times reported that the Biden Administration would add two dozen Chinese companies to the entity list while there could be additions to the investment blacklist too.
There was a big drop in biotech stocks in Hong Kong on the news with the Hang Seng Hong Kong listed Biotech Index dropping over 7%.
Ahead of the publication of the lists on Thursday, we look at the potential impact on the stocks that could be added to either/both the lists.


Potential Blacklist Additions: Impact on China AI/Biotech Stocks

<ul>
<li>
<a href="https://www.smartkarma.com/entities/sensetime-group" target="_blank" data-smartkarma-citation="entities:34319:1" rel="noopener">SenseTime Group (1475539D HK)</a> is the largest AI software company in Asia as measured by revenue in 2020. It has launched an HKEx IPO to raise up to US$767 million.  </li>
<li>In <a href="https://www.smartkarma.com/insights/sensetime-ipo-initiation-big-brother" target="_blank" data-smartkarma-citation="insights:62104" rel="noopener">SenseTime IPO Initiation: Big Brother</a>, we stated that the negatives outweigh the positives and we would give the IPO a pass. </li>
<li>Our valuation analysis suggests that the IPO price is unattractive. We would give the IPO a pass. Pricing is expected on 10 December with a listing on 17 December.</li>
</ul>



SenseTime Group (1475539D HK) is the largest AI software company in Asia as measured by revenue in 2020. It has launched an HKEx IPO to raise up to US$767 million.  
In SenseTime IPO Initiation: Big Brother, we stated that the negatives outweigh the positives and we would give the IPO a pass. 
Our valuation analysis suggests that the IPO price is unattractive. We would give the IPO a pass. Pricing is expected on 10 December with a listing on 17 December.


<ul>
<li>
<a href="https://www.smartkarma.com/entities/sensetime-group" target="_blank" data-smartkarma-citation="entities:34319:1" rel="noopener">SenseTime Group (1475539D HK)</a> is the largest AI software company in Asia as measured by revenue in 2020. It is set to launch an HKEx IPO to raise US$770 million.  </li>
<li>The fundamentals are mixed as high growth is accompanied by high customer concentration, an uncertain path to profitability, cash burn and moral concerns around “ethnic profiling software”. </li>
<li>Overall, we believe the negatives outweigh the positives and we would give the IPO a pass. </li>
</ul>



SenseTime Group (1475539D HK) is the largest AI software company in Asia as measured by revenue in 2020. It is set to launch an HKEx IPO to raise US$770 million.  
The fundamentals are mixed as high growth is accompanied by high customer concentration, an uncertain path to profitability, cash burn and moral concerns around “ethnic profiling software”. 
Overall, we believe the negatives outweigh the positives and we would give the IPO a pass. 


China

Beijing Megvii Co Ltd ("Face++") develops and distributes software products. The Company produces dynamic face recognition softwares, in vivo detection softwares, portrait library retrieval softwares and other products. Beijing Megvii also operates investment management, asset management, and other businesses.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Megvii Technology (1119636D CH)

AInnovation Technology IPO Initiation: Code Amber

AInnovation is set to launch an HKEx IPO to raise up to US$157 million. Overall, we believe the negatives outweigh the positives and we would give...

Arun George

SenseTime IPO: Relaunched but Remains a Pass

SenseTime has relaunched its HKEx IPO with an unchanged IPO price range and target raise of up to US$768 million. Our DCF sensitivity analysis...

Arun George

Potential Blacklist Additions: Impact on China AI/Biotech Stocks

An FT article said that the Biden administration would add 8 entities to the NS-CMIC list and 24 entities to the Entity List. We look at the...

Brian Freitas

SenseTime IPO: Valuation Insights

Our valuation analysis suggests that the IPO price is unattractive. We would give the IPO a pass. Pricing is expected on 10 December with a listing...

Arun George

SenseTime IPO Initiation: Big Brother

SenseTime is set to launch an HKEx IPO to raise US$770 million. Overall, we believe the negatives outweigh the positives and we would give the IPO...

Arun George

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)